Connect with us

Technology

In-Licensing Opportunity: How a Pharma Leader Leveraged Scientific Innovation for Clinical and Commercial Success | DelveInsight

Published

on

A leading U.S.-based drug delivery device company known for its strong global commercial presence recognized this opportunity and aimed to expand its portfolio through in-licensing pharma innovation. With an increasing focus on patient-friendly drug administration, the company sought to in-license a dissolvable microneedle technology (dMTS)—a non-invasive platform capable of delivering a variety of drugs and vaccines through a patch format. However, the road to in-licensed products was not without hurdles.

LAS VEGAS, March 24, 2025 /PRNewswire/ — The objective was to assess dissolvable microneedle technology and identify top licensing partner companies with the right technological competencies, clinical capabilities, and commercial readiness using secondary and primary intelligence. The company needed a comprehensive pharma market assessment to evaluate potential partners developing innovative dMTS-based drug delivery systems, ensuring they had the expertise to bring novel concepts from the lab to clinical trials and, ultimately, the market.

Recognizing the situation’s complexity and the advantages of in-licensing and out-licensing, the company turned to DelveInsight, a trusted expert in pharma market intelligence and strategic licensing. Using a combination of secondary and primary intelligence, DelveInsight conducted a deep dive into the pharma in-licensing landscape, identifying the most promising players in the microneedle technology space. The assessment provided the company with a clear roadmap—pinpointing potential partners, evaluating their clinical pipelines, and determining their in-licensing agreement potential.

In the evolving pharmaceutical landscape, bridging the gap between scientific innovation and commercial success is a persistent challenge. Many blockbuster drugs and drug delivery technologies originate from smaller biotech firms or academic research centers, where groundbreaking discoveries happen, but commercial expertise is often lacking. This is where pharma in-licensing becomes a game-changer—allowing large players to acquire cutting-edge innovations and propel them toward clinical development and market success.

Looking for the right in-licensing opportunities? Reach out to us today! Get a tailored proposal and let DelveInsight guide you with expert market intelligence and strategic licensing support.

DelveInsight’s Methodology: A Strategic Approach to In-Licensing dMTS Technology

To help the company identify the right in-licensing opportunity in dissolvable microneedle technology (dMTS), DelveInsight applied a structured, intelligence-driven approach. By leveraging its expertise in pharma licensing services and conducting comprehensive assessments, DelveInsight provided actionable insights that enabled the company to make informed decisions for in-licensing pharma assets.

dMTS Market Assessment: DelveInsight conducted an in-depth pharma market assessment, analyzing the Asia-Pacific landscape for dissolvable microneedle technology and identifying growth trends, key players, and competitive positioning in the in-licensed products space.Company Assessment: DelveInsight evaluated potential licensing partners, assessing their technological capabilities, clinical progress, and commercial readiness to support a successful in-licensing agreement.Technology Assessment: A detailed review of R&D innovations, product pipelines, and formulation technology helped determine the feasibility of in-licensing drugs from top microneedle technology developers.Investment Assessment: DelveInsight analyzed funding patterns, partnerships, and acquisition trends within the dMTS sector, ensuring that potential pharma in-licensing partners had strong financial backing and a robust growth strategy.Primary Assessment: Using primary intelligence, DelveInsight conducted expert interviews, industry surveys, and KOL engagements, validating key findings and gaining deeper insights into the capabilities of potential partners.Strategic Insights on Companies: DelveInsight provided a detailed competitive analysis, highlighting the strengths, weaknesses, opportunities, and risks of various in-licensing opportunities to ensure the client partnered with the most viable company.Assessment of Own Company: By analyzing the client’s existing portfolio, commercial strengths, and expansion goals, DelveInsight identified gaps and strategic areas for growth, ensuring a strong alignment with the selected in-licensing and out-licensing in pharma opportunities.Strategic Goal Building: Finally, DelveInsight helped the company develop a clear roadmap for in-licensing success, outlining potential partnerships, deal structures, and commercialization strategies to drive clinical development and commercial milestone achievement.

Through this intelligence-backed methodology, DelveInsight provided the client with a data-driven, strategic approach to in-licensing, enabling them to secure the right licensing opportunity and expand their footprint in the drug delivery technology market.

Strategic Outcomes with DelveInsight’s Licensing Expertise:

Matrix Analysis identified and positioned the top 20 potential licensing partners based on their technological, clinical, and commercial capabilities.The client gained a clear assessment of the top companies best aligned with their strategic goals and licensing objectives (the TARGET quadrant).DelveInsight facilitated direct meetings with 4-5 high-potential companies, enabling the client to advance in-licensing discussions efficiently.

By leveraging DelveInsight’s expertise, the company successfully secured a high-value in-licensing opportunity, giving a scientific innovation the boost it needed to reach clinical development and commercial milestone achievement. This case underscores the benefits of in-licensing—a strategic approach that enables large pharmaceutical players to stay ahead of the competition by integrating cutting-edge research into their pipelines while ensuring that breakthrough therapies reach the market faster.

Exciting, isn’t it? Don’t just watch innovation happen—secure it! Explore top in-licensing opportunities with our expert guidance.

Regulatory Analysis: DelveInsight’s regulatory intelligence services simplify global approvals by consolidating complex regulatory data into a single platform. With ever-changing guidelines and country-specific requirements, navigating approvals for NCEs, biologics, biosimilars, and cell or gene therapies can be daunting. A single misstep can mean costly delays. Our experts provide clear, comparative insights into global regulatory frameworks, helping clients streamline approvals, mitigate risks, and prioritize markets with faster access.

Portfolio Management: DelveInsight’s Portfolio Management services help clients assess competencies, leverage strengths, and align strategic priorities. Our structured approach identifies market needs, optimizes resources, and enhances portfolio value. With comprehensive market intelligence, we empower organizations to make informed, data-driven decisions, minimizing risks and maximizing long-term impact for both customers and the company.

R&D Analysis: DelveInsight’s skilled research and development analyst specializes in the complexities of different indications, offering essential insights and advice to clients aiming to advance in research and development. They utilize a methodical assessment approach, aligned with industry norms, to track the progress of each drug in both pre-clinical and clinical stages. DelveInsight’s comprehensive reports are crafted to reduce uncertainties and highlight overlooked areas, providing organizations with timely and strategic intelligence.

Why Choose DelveInsight?

DelveInsight’s Licensing Services help pharma companies secure the best in-licensing and out-licensing opportunities by identifying strategic partners and facilitating successful deal-making. With expertise across all therapeutic areas and a vast global network, we provide comprehensive market intelligence, decision-mapping matrix assessments, and expert engagement services to streamline the licensing process. Our approach ensures that clients receive a curated list of potential partners, expert-led discussions, and in-depth strategic insights, making licensing decisions more effective and result-driven. In an industry where the right partnerships drive commercial success, DelveInsight’s systematic methodology ensures seamless negotiations and long-term growth.

Ready to find the perfect licensing partner? Let’s connect!

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform, PharmDelve.

Contact Us
Shruti Thakur
info@delveinsight.com
+14699457679

Logo: https://mma.prnewswire.com/media/1082265/3528414/DelveInsight_Logo.jpg 

 

View original content:https://www.prnewswire.co.uk/news-releases/in-licensing-opportunity-how-a-pharma-leader-leveraged-scientific-innovation-for-clinical-and-commercial-success–delveinsight-302407772.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

IW247 Redefines Online Gaming

Published

on

By

HYDERABAD, India, April 2, 2025 /PRNewswire/ — IW247, a leading online gaming platform, is setting a new standard for gaming with around-the-clock opportunities to win. The platform is dedicated to providing uninterrupted action, bringing the gaming experience into a new era where ‘I WIN’ is at the core of everything.

What’s Behind the Name?

The ‘247’ in IW247 represents 24/7, symbolizing continuous gaming action, limitless excitement, and non-stop chances to win. IW247 is committed to delivering a superior, round-the-clock gaming experience for players worldwide.

What’s New with IW247?

IW247 offers several enhancements designed to improve the gaming experience:

Faster Performance – Enjoy seamless gameplay with quick navigation and responsiveness.Stronger Security – Enhanced protection features ensure the safety of both winnings and personal data.Smoother User Experience – An intuitive interface designed for ease of use.Revamped Visuals – A modern design reflecting a competitive and dynamic gaming spirit.Exciting New Games – A growing selection of games that provide continuous thrill.Exclusive Promotions – Engaging challenges, special rewards, and offers to keep players engaged.

A Gaming Platform for the Future

IW247 is more than just an online gaming platform—it represents a shift in the gaming experience itself. Whether you’re a casual gamer or a seasoned player, IW247 inspires players to dream bigger, play smarter, and win harder.

The future of gaming is here, where the game never stops, and neither does the chance to win.

About IW247

IW247 is an online gaming platform that offers a dynamic, secure, and user-friendly experience. With a wide variety of live casinos, sports betting, slots, instant games, and exclusive promotions, IW247 is designed to meet the needs of players who seek constant action and the thrill of winning. Built on cutting-edge technology, IW247 is committed to providing an innovative, 24/7 gaming experience where players can win anytime, anywhere.

Media Contact:

Site: https://bit.ly/iwsite
IG – https://www.instagram.com/iw247official/
FB – https://www.facebook.com/iw247official
X – https://x.com/iw247official
Threads – https://www.threads.net/@iw247official
YT – https://www.youtube.com/@iW247Official

Photo: https://mma.prnewswire.com/media/2655109/IW247_upgrades.jpg
Logo: https://mma.prnewswire.com/media/2655108/IW247_Logo.jpg

View original content to download multimedia:https://www.prnewswire.com/in/news-releases/iw247-redefines-online-gaming-302418143.html

Continue Reading

Technology

Jiangxi-GBA Economic Cooperation Promotion Held Successfully

Published

on

By

SHENZHEN, China, April 2, 2025 /PRNewswire/ — A report from Jiangxi International Communication Center(JXICC): On April 1, 2025, the Jiangxi & Greater Bay Area(GBA) Economic and Trade Cooperation Promotion Conference was held in Shenzhen, China. This event marked the 23rd consecutive year that Jiangxi has organized a major economic and trade event in the GBA, with the aim of further enhancing collaboration and exchanges while promoting high-level open development in Jiangxi.

During the conference, Jiangxi highlighted its significant achievements in transportation connectivity, economic and trade collaboration, and industrial synergy. The opening of the Ganzhou-Shenzhen High-Speed Railway has reduced travel time between the two regions to just two hours, facilitating cooperation. In terms of economic and trade cooperation, the GBA has become a primary destination for Jiangxi’s investment initiatives, with over 30% of Jiangxi’s project funding coming from Guangdong, and more than 80% of the foreign capital utilized in Jiangxi coming from Hong Kong and Macao. Jiangxi also plays a crucial role as an agricultural product supplier for the GBA, achieving fruitful results in industrial coordination and resource sharing for both regions.

The conference also emphasized new opportunities in technological innovation and industrial development in Jiangxi. The province is actively implementing an innovation-driven development strategy, accelerating the digital transformation of manufacturing, and fostering emerging industries. Currently, Jiangxi boasts multiple national and provincial advanced manufacturing clusters, with a modern industrial system quickly taking shape. Additionally, initiatives such as the establishment of industrial guidance funds have attracted capital from the GBA to support industrial growth. By the end of 2024, the total scale of these funds had reached 320.184 billion yuan, facilitating the initiation of several major projects in Jiangxi.

A signing ceremony for cooperative projects was held during the event, resulting in the signing of 83 projects worth a total of 45.046 billion yuan. These projects cover key infrastructure construction, critical manufacturing industry chains, the health industry, and other sectors, injecting new vitality into Jiangxi’s economic development.

The successful hosting of this conference signifies that economic and trade cooperation between Jiangxi and the GBA has reached a new level. Both sides aim to work together to write a new chapter in the modernization of China.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/jiangxi-gba-economic-cooperation-promotion-held-successfully-302418168.html

SOURCE Jiangxi International Communication Center(JXICC)

Continue Reading

Technology

Huawei puts scenario-based solutions in the spotlight for its Europe Enterprise Roadshow 2025

Published

on

By

From AI-ready storage to intelligent campus networks: Huawei highlights application-focused solutions as the central theme for digital and intelligent transformation of industries in Europe

DÜSSELDORF, Germany, April 2, 2025 /PRNewswire/ —  Huawei has kicked off its annual Europe Enterprise Roadshow, an initiative that sees an expandable truck with the latest scenario-centric ICT technologies travel across Europe to connect with customers, partners, and CXO executives.

The roadshow truck will visit 29 cities in 17 European countries with the message to “Accelerate Industrial Digital Intelligence”, serving as a mobile exhibition space to showcase Huawei’s latest solutions in data communications, data storage and optical networking. This year the mobile technology center will also purposefully focus on adaptive solutions designed for specific use cases to aid European industries in their quest for digital transformation.

The primary goal of the roadshow is to assist European companies and public sector institutions in speeding up their digital transition and embracing digital intelligence. Last year, the roadshow attracted more than 7,000 visitors.

“With the European Enterprise Roadshow 2025, we underline our commitment to digital and intelligent transformation in Europe,” explains Willi Song, President, Huawei European Enterprise Business. “This year, we are placing a special focus on industry-specific scenarios and strengthening our partner ecosystem. This allows us to show our customers and partners more specifically how our solutions address their individual challenges and drive transformation.”

Digital intelligence is gaining momentum in Europe

Europe is on the brink of profound change through the interplay of artificial intelligence, rapidly growing data volumes, faster networks and high-performance computing power. This in turn affects digital transformation in all sectors of the economy and promises to sustainably improve society, industries, and the environment. The enterprise roadshow showcases practical solutions on how to achieve this.

In civic administrations, public offices begin to offer personalized citizen services, while smart cities are evolving into intelligent living spaces. The healthcare industry adopts IoT technologies to improve patient care and academic research benefits from powerful AI storage solutions. Educational institutions are moving towards complete digitization while retail is implementing new, customer-oriented concepts.

“The technology is mature, the tools are ready – now is the right time to accelerate digital and intelligent transformation in Europe and fully exploit its benefits,” adds Song.

Storage, campus networks, and optical: Industry-specific solutions in focus

The Huawei Enterprise Roadshow 2025 presents a wide range of innovative ICT solutions for multiple industries. Huawei showcases its “Future-Proof Data Storage” technology to let companies unleash the value of exponentially growing data in the AI era. For modern campus environments, the “Xinghe Intelligent Campus” system offers a holistic, AI-supported infrastructure with Huawei’s unique Wi-Fi 7 technologies such as smart antennas and intelligent scheduling, VIP experience assurance, Wi-Fi Shield or AI-powered energy saving. The “All-Optical Network” solution promises ultra-fast, reliable connectivity for various application scenarios. In the education sector, Huawei demonstrates its “Research Data Management” system, which supports research institutions in efficiently managing large data volumes, as well as the “Education Campus Network” solution for a fully digitalized learning environment. For the public sector, the “Smart City” platform is introduced to help public administrations rapidly promote inclusive network coverage, improve civic services, and bridge the digital divide. In healthcare, Huawei presents the “HIS&PACS A-A-Unified Storage” solution for seamless integration of hospital information, picture archiving and communication storage systems. Among other products, Huawei will include its “Multi-Branch Retail Solution” for retailers and “Managed Wi-Fi Service for MSPs as well as “FTTO Solution for Hotels” to provide a fiber-optic network infrastructure for the hospitality industry and other sectors.

“Our industry-specific adaptations of storage, network, and optical solutions enable companies to achieve optimal performance according to their individual requirements,” says Song. “This way, we can support many industries and companies in accelerating transformation in Europe and promoting the adoption of digital intelligence.”

HUAWEI eKit and expanded partner ecosystem

A new addition to the Roadshow 2025 is HUAWEI eKit, the sub-brand for the distribution business in the SMB sector. The platform, active in over 100 countries, offers partners comprehensive solutions for transactions, operations, and marketing. The goal of HUAWEI eKit is to simplify deployments by providing solutions that are easy to manage and install, ensuring end-to-end simplicity for small and medium-sized businesses.

Additionally, Huawei provides its partners with comprehensive service packages. At the highest service level, Huawei enables the delivery of replacement parts within four hours. In customer support, Huawei offers hotline support in 18 languages for 33 countries and fast response times within five minutes.

The Roadshow enables valuable networking and local collaboration  

At each stop of the roadshow, the truck becomes a walk-in exhibition stand with a total of 15 stations. From individual product areas to industry applications and flexible multi-solutions and services, each station offers deep and detailed insights. Huawei professionals are available at each location to present solutions and answer questions. Additionally, the roadshow truck provides a stage for local in-country events, such as panel discussions, presentations of user scenarios, customer sharing, product training, networking, Q&A sessions, or award events.

The Huawei Enterprise Roadshow 2025 runs from March to September and makes stops in key cities in France, Germany, Switzerland, the Netherlands, Turkey, and Poland, among others.

For more information, visit https://e.huawei.com/eu/events/2025/eu/roadshow-2025/huawei-enterprise-roadshow-2025

About Huawei

Huawei is a leading global provider of Information and Communication Technology (ICT) solutions, infrastructures and smart devices. With integrated solutions in four key environments: telecommunications networks, IT, smart devices and cloud services, we are committed to bringing digitization to every person, home and organization for a fully connected and intelligent world.

Huawei’s complete portfolio of products, solutions and services is competitive and secure. Through collaboration with ecosystem partners, we create added value for our customers and work to empower people, enrich life in homes and inspire innovation in organizations of all kinds.

At Huawei, innovation focuses on customer needs. We invest heavily in research, focusing on the technological advances that drive the world forward. We currently have more than 207,000 employees and operate in more than 170 countries and regions. Founded in 1987, Huawei is a privately held company wholly owned by its employees. For more information, please visit Huawei online.

Photo: https://mma.prnewswire.com/media/2652912/Huawei.jpg
Logo: https://mma.prnewswire.com/media/2559207/5239435/Huawei_Europe_Logo.jpg

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/huawei-puts-scenario-based-solutions-in-the-spotlight-for-its-europe-enterprise-roadshow-2025-302414441.html

Continue Reading

Trending